Literature DB >> 15785009

White-coat hypertension contributes to the presence of carotid arteriosclerosis.

Takao Nakashima1, Shigeru Yamano, Rie Sasaki, Shigetoshi Minami, Kazuhiro Doi, Junko Yamamoto, Minoru Takaoka, Yoshihiko Saito.   

Abstract

It remains unclear whether white-coat hypertension is associated with vascular organ damage (e.g., carotid arteriosclerosis) in the same way sustained hypertension is. We therefore compared the progression of carotid arteriosclerosis among Japanese individuals showing normal blood pressures, sustained hypertension or white-coat hypertension. A total of 30 subjects (mean age, 58 years) with white-coat hypertension, 30 (mean age, 54 years) with untreated sustained hypertension who had no plaque formation in the carotid arteries, and 30 normotensive subjects (mean age, 58 years) were enrolled in this study. The white-coat and sustained hypertensive subjects were matched with respect to their clinical blood pressures, but their ambulatory blood pressures differed. Conversely, white-coat hypertensive and normotensive subjects were matched with respect to ambulatory blood pressures, but their clinical blood pressures differed. Carotid intimal-medial thickness was measured by B-mode ultrasonography, and the cross-sectional area of the common carotid artery was calculated. The three groups were similar with respect to age, sex ratio, height, laboratory data and the incidence of smoking. Body weights and body mass indexes were significantly higher among patients with sustained hypertension than among either normotensive or white-coat hypertensive patients. Intimal-medial thicknesses and carotid cross-sectional areas were similar in patients with white-coat and sustained hypertension and significantly higher than in normotensive subjects. Collectively, these findings suggest that white-coat hypertension contributed to the presence of carotid arteriosclerosis in our subjects in a manner similar to sustained hypertension. Thus, clinical evaluation of white-coat hypertension should be conducted with the potential for target organ damage in mind.

Entities:  

Mesh:

Year:  2004        PMID: 15785009     DOI: 10.1291/hypres.27.739

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  7 in total

Review 1.  Diagnosis and management of patients with white-coat and masked hypertension.

Authors:  Giuseppe Mancia; Michele Bombelli; Gino Seravalle; Guido Grassi
Journal:  Nat Rev Cardiol       Date:  2011-08-09       Impact factor: 32.419

2.  Endothelial damage in white coat hypertension: role of lectin-like oxidized low-density lipoprotein-1.

Authors:  S Yavuzer; H Yavuzer; M Cengiz; H Erman; M R Altıparmak; B Korkmazer; H Balci; G Simsek; A L Yaldıran; Y Karter; H Uzun
Journal:  J Hum Hypertens       Date:  2014-07-10       Impact factor: 3.012

3.  Ambulatory blood pressure monitoring in the elderly.

Authors:  Juan Diego Mediavilla García; Fernando Jaén Águila; Celia Fernández Torres; Blas Gil Extremera; Juan Jiménez Alonso
Journal:  Int J Hypertens       Date:  2011-12-20       Impact factor: 2.420

4.  Differential expression of hypertension-associated microRNAs in the plasma of patients with white coat hypertension.

Authors:  Mahir Cengiz; Omer Faruk Karatas; Erkan Koparir; Serap Yavuzer; Chayar Ali; Hakan Yavuzer; Emre Kirat; Yesari Karter; Mustafa Ozen
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

5.  Prevalence, predictive factor, and clinical significance of white-coat hypertension and masked hypertension in Korean hypertensive patients.

Authors:  Eui-Seock Hwang; Kee-Joon Choi; Duk-Hyun Kang; Gi-Byoung Nam; Jae-Sik Jang; Young-Hoon Jeong; Chang-Hoon Lee; Ji-Young Lee; Hyun-Koo Park; Chong-Hun Park
Journal:  Korean J Intern Med       Date:  2007-12       Impact factor: 2.884

6.  Comparison of pulse wave analysis between persons with white coat hypertension and normotensive persons.

Authors:  Neil J Wimmer; Kinji Sathi; Tiffany L Chen; Raymond R Townsend; Debbie L Cohen
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-07       Impact factor: 3.738

7.  Should white coat hypertension be treated?

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-09       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.